Draft guideline on computerised systems and electronic ...
Guideline on computerised systems and electronic data in clinical trials EMA/226170/2021 Page 5/47 122 Glossary and abbreviations 123 Generally used terms 124 Unless otherwise specified (e.g. “source data” or “source document”) and in order to simplify the text,
Download Draft guideline on computerised systems and electronic ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Quality Management in Clinical Trials - Pfizer
cdn.pfizer.comrequirements, and GCP standards in conducting the trial. Sponsors of clinical research have a broad range of obligations including responsibly selecting, training, and supporting investigators and monitors. These obligations have a direct impact on thousands of …
Checklist for Evaluating Whether a Clinical Trial or Study ...
prsinfo.clinicaltrials.govJun 27, 2018 · Checklist for Evaluating Whether a Clinical Trial or Study is an Applicable Clinical Trial (ACT) Under 42 CFR 11.22(b) for Clinical Trials Initiated on or After January 18, 20171 (NOT FOR SUBMISSION2) Instructions: Answer the following questions to evaluate whether the study is an applicable clinical trial (ACT). Use the
Guideline Adjustment Baseline Covariates Clinical Trials
www.ema.europa.euHowever, conducting exploratory analyses including such variables when large baseline imbalances are observed might be helpful to assess ... The note for guidance on statistical principles for clinical trials (ICH E9) briefly addresses the problem of adjustment for covariates. It advises experimenters ‘to identify the covariates expected to ...
Australian clinical trial handbook
www.tga.gov.auClinical Trials Toolkit on the Australian Clinical Trials website for further information and useful resources. Before conducting a clinical trial in Australia, the trial spo nsor will need to consult a HREC to determine whether an exemption under the CTN scheme or approval under the CT A scheme is required for the trial.